SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001437749-17-012650
Filing Date
2017-07-17
Accepted
2017-07-14 17:34:02
Documents
23
Filing Date Changed
2017-07-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 16020
2 neurmed20170711_1e.htm PART II AND III 1405932
3 ex1-6a.htm EX1A-6 MAT CTRCT 33038
4 ex1-6b.htm EX1A-6 MAT CTRCT 1676931
5 ex1-6c.htm EX1A-6 MAT CTRCT 737263
6 ex1-6d.htm EX1A-6 MAT CTRCT 17740
7 ex1-6e.htm EX1A-6 MAT CTRCT 444095
8 ex1-6f.htm EX1A-6 MAT CTRCT 740320
9 ex1-6g.htm EX1A-6 MAT CTRCT 178950
10 ex1-11a.htm EX1A-11 CONSENT 3299
11 ex1-12a.htm EX1A-12 OPN CNSL 11660
12 a1.jpg GRAPHIC 10348
13 a3.jpg GRAPHIC 16360
14 b1.jpg GRAPHIC 34874
15 ckr1.jpg GRAPHIC 4248
16 ex1-6bimg001.jpg GRAPHIC 2848
17 ex1-6bimg002.jpg GRAPHIC 106012
18 ex1-6bimg003.jpg GRAPHIC 38921
19 image2.jpg GRAPHIC 51909
20 image3.jpg GRAPHIC 53324
21 sig1.jpg GRAPHIC 9806
22 v1.jpg GRAPHIC 5986
23 v2.jpg GRAPHIC 17760
  Complete submission text file 0001437749-17-012650.txt   5752955
Mailing Address 11601 WILSIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 3104444321
Neurmedix, Inc. (Filer) CIK: 0001704466 (see all company filings)

IRS No.: 472860346 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 1-A/A | Act: 33 | File No.: 024-10697 | Film No.: 17966213
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1